LUNG

PULMONX CORP

LUNG·745848101·US·Common Stock·Healthcare - Medical Devices-13D/G

LUNG (PULMONX CORP) is held by 72 institutional investors as of Q1 2026. Largest holders: PRIMECAP MANAGEMENT CO/CA/ ($6.1M), MORGAN STANLEY ($5.2M), BlackRock, Inc. ($3.4M). Net institutional sentiment: Mixed.

72
Holders
Avg rating(17 Elite)
$32.1M
Total Value
49% (78)
Fund Consensus
34 buying - 35 selling
LUNGSmart Money Verdict
View all
Held by 72 funds
17 elite
Who's Trading
InsiderRSRadhakrishnan SrikanthSell $4KJun 1, 2026
InsiderRSRadhakrishnan SrikanthSell $3KJun 1, 2026
InsiderRSRadhakrishnan SrikanthSell $6KJun 1, 2026
InsiderRSRadhakrishnan SrikanthSell $9KJun 1, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
ActivistSMSoleus Capital Master Fund, L.P.6.5%Mar 9, 2026
InsiderFIFrench Glendon E. IIISell $4KMar 2, 2026
InsiderFIFrench Glendon E. IIISell $10KMar 2, 2026
InsiderFIFrench Glendon E. IIISell $83KMar 2, 2026
InsiderRBRose Geoffrey BeranSell $1KMar 2, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
4.7M(-0.1%)$6.1M0.0%-95.98%
0
Decreased
4M(-4.0%)$5.2M0.0%-73.69%
0
Decreased
2.7M(-1.6%)$3.4M0.0%-76.87%
0
Decreased
1.9M(-0.4%)$2.5M0.0%-32.46%
0
New
1.6M$2.1M0.0%+0.65%
36
Increased
1.2M(+60.3%)$1.5M0.0%-35.51%
37
Increased
1.2M(+3.4%)$1.5M0.0%-82.78%
26
Increased
944,492(+4.2%)$1.2M0.0%-94.94%
26
Decreased
809,116(-1.5%)$1M0.0%-86.55%
0
Increased
683,435(+44.7%)$881,6320.0%-52.20%
34
New
604,455$779,7470.0%+0.65%
38
Increased
357,578(+506.9%)$461,2760.0%-20.66%
39
Decreased
388,103(-9.1%)$457,9620.0%-77.05%
0
Increased
354,674(+5.2%)$457,5290.0%-95.57%
25
Decreased
335,074(-40.3%)$432,2460.0%-76.35%
0
Increased
320,300(+9.7%)$413,1870.0%-71.72%
26
Unchanged
285,110$367,7920.0%-77.05%
0
New
281,248$362,8100.0%+0.65%
33
Decreased
223,450(-38.8%)$288,2510.0%-63.35%
0
Increased
209,701(+22.2%)$270,5140.0%-45.90%
19

Showing 1-20 of 78

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used